141 related articles for article (PubMed ID: 15115664)
1. Aspirin resistance and diabetic angiopathy: back to the future.
Di Minno G; Violi F
Thromb Res; 2004; 113(2):97-9. PubMed ID: 15115664
[No Abstract] [Full Text] [Related]
2. The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study.
DiChiara J; Bliden KP; Tantry US; Hamed MS; Antonino MJ; Suarez TA; Bailon O; Singla A; Gurbel PA
Diabetes; 2007 Dec; 56(12):3014-9. PubMed ID: 17848625
[TBL] [Abstract][Full Text] [Related]
3. Lack of aspirin-induced decrease in thrombin formation in subjects resistant to aspirin.
Undas A; Placzkiewicz-Jankowska E; Zieliński L; Tracz W
Thromb Haemost; 2007 Jun; 97(6):1056-8. PubMed ID: 17549314
[No Abstract] [Full Text] [Related]
4. Aspirin resistance and platelet turnover: a 25-year old issue.
Di Minno G
Nutr Metab Cardiovasc Dis; 2011 Aug; 21(8):542-5. PubMed ID: 21745731
[TBL] [Abstract][Full Text] [Related]
5. Aspirin resistance, platelet turnover, and diabetic angiopathy: a 2011 update.
Di Minno MN; Lupoli R; Palmieri NM; Russolillo A; Buonauro A; Di Minno G
Thromb Res; 2012 Mar; 129(3):341-4. PubMed ID: 22142668
[TBL] [Abstract][Full Text] [Related]
6. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
[TBL] [Abstract][Full Text] [Related]
7. Drug insight: aspirin resistance-fact or fashion?
Maree AO; Cox D; Fitzgerald DJ
Nat Clin Pract Cardiovasc Med; 2007 Mar; 4(3):E1; author reply E2. PubMed ID: 17330121
[No Abstract] [Full Text] [Related]
8. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
[TBL] [Abstract][Full Text] [Related]
9. Aspirin resistance: what, why and when?
Shantsila E; Watson T; Lip GY
Thromb Res; 2007; 119(5):551-4. PubMed ID: 17010411
[No Abstract] [Full Text] [Related]
10. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T
Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
[TBL] [Abstract][Full Text] [Related]
11. Variable platelet response to aspirin in patients with ischemic stroke.
Hohlfeld T; Weber AA; Junghans U; Schumacher M; Boucher M; Schrör K; Siebler M
Cerebrovasc Dis; 2007; 24(1):43-50. PubMed ID: 17519543
[TBL] [Abstract][Full Text] [Related]
12. Laboratory detection of 'aspirin resistance': what test should we use (if any)?
Cattaneo M
Eur Heart J; 2007 Jul; 28(14):1673-5. PubMed ID: 17586540
[No Abstract] [Full Text] [Related]
13. Aspirin, prostaglandins, and peripheral gangrene.
Preston FE
Am J Med; 1983 Jun; 74(6A):55-60. PubMed ID: 6859070
[No Abstract] [Full Text] [Related]
14. Drug insight: aspirin resistance--fact or fashion?
Patrono C; Rocca B
Nat Clin Pract Cardiovasc Med; 2007 Jan; 4(1):42-50. PubMed ID: 17180149
[TBL] [Abstract][Full Text] [Related]
15. Comment on: DiChiara et al. (2007) The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study: Diabetes 56:3014-3019, 2007.
Klein PS
Diabetes; 2008 May; 57(5):e10; author reply e11. PubMed ID: 18443367
[No Abstract] [Full Text] [Related]
16. Clinical determinants of aspirin resistance in diabetes.
Yassine HN; Davis-Gorman G; Stump CS; Thomson SS; Peterson J; McDonagh PF
Diabetes Res Clin Pract; 2010 Oct; 90(1):e19-21. PubMed ID: 20719400
[TBL] [Abstract][Full Text] [Related]
17. Gallic acid, a dietary polyphenolic component, blunts the inhibition of platelet COX-1 by aspirin: preliminary in-vitro findings.
Crescente M; Cerletti C; de Gaetano G
Thromb Haemost; 2007 Jun; 97(6):1054-6. PubMed ID: 17549313
[No Abstract] [Full Text] [Related]
18. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance".
Santilli F; Rocca B; De Cristofaro R; Lattanzio S; Pietrangelo L; Habib A; Pettinella C; Recchiuti A; Ferrante E; Ciabattoni G; Davì G; Patrono C
J Am Coll Cardiol; 2009 Feb; 53(8):667-77. PubMed ID: 19232899
[TBL] [Abstract][Full Text] [Related]
19. Terms and conditions: semantic complexity and aspirin resistance.
Hennekens CH; Schror K; Weisman S; FitzGerald GA
Circulation; 2004 Sep; 110(12):1706-8. PubMed ID: 15381661
[No Abstract] [Full Text] [Related]
20. Effect of changes in prostaglandin synthesis by platelets and vessel wall on the formation of arterial thrombosis in rabbits.
Kobayashi N; Takada M; Andou K; Maekawa T
Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():521-2. PubMed ID: 2936159
[No Abstract] [Full Text] [Related]
[Next] [New Search]